Purpose of Study
This clinical investigation is intended to evaluate the dafety and effectiveness of the AveirTM Dual-Chamber (DR) Leadless Pacemaker (LP) system.
Trial Status
Closed, FDA Approved
Eligibility Criteria
Must be 18 years of age, life expectancy of at least 1 year, willing to comply with procedures and required follow-up visits, tests, and exams
Duration of Participation
Approxmiately 12-20 months
Contact Name: Rachel Hackett, RN
Contact Phone: 515-633-3845
Contact Email: rachel.hackett@mercyoneiowa.org